At Iterative Health, we are a pioneer in the application of artificial intelligence-based precision medicine to gastroenterology with the aim of establishing a new standard of care for the detection, and ultimately, treatment of gastrointestinal (GI) diseases. Our powerful, proprietary artificial intelligence and computer vision technologies are designed with the goal of improving the accuracy and consistency of endoscopy readings.

We believe the work underway at Iterative Health will lead to better patient care, allowing people suffering from IBD – and, eventually, other GI diseases – to improve their quality of life, relationships with their doctors, and access to clinical trials and potential therapeutic advances. ​And we're a group of dedicated, passionate people who find energy in working together to address these big challenges. We're headquartered in Cambridge, not far from MIT, where we were founded in 2017